Clinical Trials

Showing 341 - 360 of 485 trials
Titlesort icon Investigator Disease(s)
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase III Study of Gemcitabine, Docetaxel, and Doxorubicin versus Observation in Women with High-Grade Uterine Leiomyosarcoma
[Protocol 12-177]
Hensley, Martee
  • Uterine Sarcoma
    • Leiomyosarcoma
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118]
Lake, Diana
  • Breast Cancer
A Phase III Study of Ibritumomab Tiuxetan versus Observation in Older Patients with Diffuse Large B-Cell Lymphoma in Remission following R-CHOP
Newly Diagnosed
[Protocol 12-061]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Ibrutinib (PCI-32765) plus R-CHOP Chemotherapy in Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL)
[Protocol 13-146]
Younes, Anas
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Inotuzumab Ozogamicin versus Standard Therapy in Patients with Persistent or Recurrent CD22-Positive Acute Lymphoblastic Leukemia
Relapsed/Refractory
[Protocol 12-262]
Park, Jae
A Phase III Study of KW-0761 versus Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma
[Protocol 13-007]
Moskowitz, Alison
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
Newly Diagnosed
[Protocol 12-018]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase III Study of MEK162 versus Dacarbazine in Patients with Inoperable or Metastatic Melanomas with NRAS Q61 Mutations: The NEMO Trial
[Protocol 13-083]
Postow, Michael
  • Melanoma
A Phase III Study of MEK162 versus Standard Chemotherapy in Patients with Recurrent or Persistent Low-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: The MILO Study
[Protocol 13-098]
Grisham, Rachel
  • Ovarian Cancer
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma
[Protocol 08-072]
Dunkel, Ira
  • Retinoblastoma
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041]
Eastham, James
  • Prostate Cancer
    • Localized Disease
A Phase III Study of Nivolumab and Ipilimumab, Together and Individually, in Patients Newly Diagnosed with Advanced Melanoma
[Protocol 13-075]
Wolchok, Jedd
  • Melanoma
A Phase III Study of Ofatumumab versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Relapsed/Refractory
[Protocol 11-079]
Matasar, Matthew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Olaparib vs Placebo as Maintenance Therapy in Women with BRCA-Mutated Advanced Ovarian Cancer After Platinum-Based Chemotherapy
[Protocol 14-036]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase III Study of Postoperative Radiation Therapy with and without Cetuximab for Locally Advanced Resected Head and Neck Cancer
[Protocol 10-081]
Lee, Nancy
  • Head & Neck Cancer
A Phase III Study of Rituximab/Lenalidomide or Rituximab/Chemotherapy Followed by Rituximab Maintenance Therapy in Patients with Previously Untreated Follicular Lymphoma
Newly Diagnosed
[Protocol 12-081]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Ruxolitinib versus Hydroxyurea to Treat Symptoms of Polycythemia Vera: the RELIEF Study
[Protocol 13-142]
Rampal, Raajit
  • Hematology
    • Hematologic Disorders
A Phase III Study of Sapacitabine in Elderly Patients Newly Diagnosed with Acute Myeloid Leukemia
Newly Diagnosed
[Protocol 12-034]
Berman, Ellin
  • Geriatrics
  • Leukemia
A Phase III Study of Sorafenib Alone versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Patients with Liver Cancer
[Protocol 13-250]
Goodman, Karyn
  • Hepatobiliary
    • Liver Cancer